|Podcasts|September 13, 2021
From Lab to Life: Accelerating End-to-End Drug Development to Bring Medicines to Patients Faster
Author(s)Syneos Health
In Episode Two of the Syneos Health Dedicated Dialogue podcast series, we reveal how harnessing broad expertise across the product development lifecycle leads to relevant, effective and efficient solutions that speed commercial success and bring novel drugs to patients sooner to improve patient care.
Related Content
Trending on PharmExec
1
FDA Files Concerns Over Missing Data for Moderna’s mRNA Flu Shot: Report
2
Where Does Boehringer Ingelheim Stand Between Oral or Injectable GLP-1’s Being The Future of Obesity Care?
3
How Behavioral and Engagement Insights Improve Persistence in Patient Support Programs
4
How is Boehringer Ingelheim's Deliberate GLP-1 Strategy Different From Competitors?
5